- Adults
- General population
- Elderly
- Paediatric
- Community
- Primary care
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Monoclonal antibodies
- Sotrovimab
- Molnupiravir
Setting: Community
A research environment where studies are conducted outside of clinical or laboratory settings, focusing on real-world populations
- Adults
- Community
- Primary care
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Nitric Oxide Nasal Spray
- Adults
- Hospital wide
- Outpatient clinic
- Community
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Acute SARS-CoV-2
- Blood sample
- Nasopharyngeal swab
- PBMC
- Stool sample
- Serum
- Whole blood
- Plasma
- Paediatric
- Hospital wide
- Outpatient clinic
- Community
- Primary care
- Non-hospital health centre
- Emergency department
- SARS-CoV-2
- Post-COVID-19
- Acute SARS-CoV-2
- Adults
- General population
- Community
- Non-hospital health centre
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Community
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Paediatric
- Hospital wide
- Outpatient clinic
- Community
- Non-hospital health centre
- SARS-CoV-2
- Acute SARS-CoV-2
- Adults
- General population
- Elderly
- Community
- Non-hospital health centre
- Long-term care facility
- Influenza virus
- Influenza A(H5N1) virus
- Influenza A(H7N9) virus
- Avian Influenza
- Pharmacological intervention
- Vaccination
- Adults
- Elderly
- Fragile population
- Outpatient clinic
- Community
- Non-hospital health centre
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Monoclonal antibodies
- Sotrovimab
- Molnupiravir
- Adults
- Elderly
- Fragile population
- Paediatric
- Immunocompromised host
- Outpatient clinic
- Community
- Non-hospital health centre
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab